Back to Partners

Ledidi + Franklin Health: Accelerating Clinical Evidence

Franklyn Health is a full-service CRO built specifically for small and mid-size device and diagnostics manufacturers. The team brings decades of experience from both sides of the sponsor–CRO relationship, and founded Franklyn with a single ambition: to be the CRO they always wished existed — responsive, consistent, and personally accountable.

At Ledidi, we built our clinical evidence platform around a simple belief: sponsors deserve direct, real-time access to their own data. Study design shouldn't require a six-month implementation cycle. And the evidence you generate should stay yours — portable, reusable, never locked inside someone else's system.

Our no-code platform is validated for GCP and FDA 21 CFR Part 11 compliance, with ISO 27001 and SOC 2 Type II certification.

Together, we give device and diagnostics companies a single, joined-up path from study design through to post-market follow-up — without unnecessary complexity or overhead. Sponsors retain ownership of their data and study designs throughout. Outsourcing expertise shouldn't mean outsourcing control.

Why Ledidi and Franklin Health Have Joined Forces

Great healthcare relies on continuous evidence, but traditional clinical data management is too slow. By combining Franklin Health’s extensive clinical ecosystem with Ledidi’s rapid evidence-generation platform, we have built a seamless highway from patient data to peer-reviewed publication. This partnership eliminates technical bottlenecks, giving Franklin Health investigators total autonomy over their data pipelines.

Partners name
Franklyn Health
Partners since
March 25, 2026
Focus
Clinical Evidence
Location
United Kingdom • Nordics (Denmark, Sweden, Norway)
Visit Partner

”Through our new collaboration with Ledidi, we are further reinforcing our emphasis on clinical registry data. With Ledidi’s unique collaborative and analytical capabilities, we are able to deliver real-time insights that will benefit Versius surgeons. The registry platform will also increase collaboration.”